These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 29250975)

  • 1. An update on emerging drugs for fibromyalgia treatment.
    Atzeni F; Gerardi MC; Masala IF; Alciati A; Batticciotto A; Sarzi-Puttini P
    Expert Opin Emerg Drugs; 2017 Dec; 22(4):357-367. PubMed ID: 29250975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel pharmaceutical options for treating fibromyalgia.
    Gerardi MC; Batticciotto A; Talotta R; Di Franco M; Atzeni F; Sarzi-Puttini P
    Expert Rev Clin Pharmacol; 2016 Apr; 9(4):559-565. PubMed ID: 26794309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential drug therapies for the treatment of fibromyalgia.
    Lawson K
    Expert Opin Investig Drugs; 2016 Sep; 25(9):1071-81. PubMed ID: 27269389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled-release pregabalin in the treatment of fibromyalgia.
    Alciati A; Atzeni F; Masala IF; Cirillo M; Sciortino D; Perna G; Sarzi-Puttini P
    Expert Rev Neurother; 2018 Aug; 18(8):617-623. PubMed ID: 30092164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New drugs or alternative therapy to blurring the symptoms of fibromyalgia-a patent review.
    Oliveira MA; Guimarães AG; Araújo AAS; Quintans-Júnior LJ; Quintans JSS
    Expert Opin Ther Pat; 2017 Oct; 27(10):1147-1157. PubMed ID: 28665159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on pharmacotherapy for the treatment of fibromyalgia.
    Calandre EP; Rico-Villademoros F; Slim M
    Expert Opin Pharmacother; 2015 Jun; 16(9):1347-68. PubMed ID: 26001183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological treatments of fibromyalgia: do complex conditions need complex therapies?
    Lawson K
    Drug Discov Today; 2008 Apr; 13(7-8):333-40. PubMed ID: 18405846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium oxybate for the treatment of fibromyalgia.
    Staud R
    Expert Opin Pharmacother; 2011 Aug; 12(11):1789-98. PubMed ID: 21679091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging therapies for fibromyalgia.
    Ablin JN; Buskila D
    Expert Opin Emerg Drugs; 2008 Mar; 13(1):53-62. PubMed ID: 18321148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of low power laser and low dose amitriptyline therapy on clinical symptoms and quality of life in fibromyalgia: a single-blind, placebo-controlled trial.
    Gür A; Karakoc M; Nas K; Cevik R; Sarac J; Ataoglu S
    Rheumatol Int; 2002 Sep; 22(5):188-93. PubMed ID: 12215864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging therapies for fibromyalgia: an update.
    Ablin JN; Buskila D
    Expert Opin Emerg Drugs; 2010 Sep; 15(3):521-33. PubMed ID: 20486862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging drugs for panic disorder.
    Perna G; Guerriero G; Caldirola D
    Expert Opin Emerg Drugs; 2011 Dec; 16(4):631-45. PubMed ID: 21999303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment.
    Mease P
    J Rheumatol Suppl; 2005 Aug; 75():6-21. PubMed ID: 16078356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the management of fibromyalgia: what is the state of the art?
    Staud R
    Expert Opin Pharmacother; 2022 Jun; 23(8):979-989. PubMed ID: 35509228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug discovery and development for fibromyalgia using practical biomarkers throughout the process from relevant animal models to patients.
    Nagakura Y; Tozaki-Saitoh H; Takeda H
    Expert Opin Drug Discov; 2023 May; 18(5):539-549. PubMed ID: 37051616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bedtime very low dose cyclobenzaprine on symptoms and sleep physiology in patients with fibromyalgia syndrome: a double-blind randomized placebo-controlled study.
    Moldofsky H; Harris HW; Archambault WT; Kwong T; Lederman S
    J Rheumatol; 2011 Dec; 38(12):2653-63. PubMed ID: 21885490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoteric pharmacotherapeutic targets in fibromyalgia.
    Chopra K; Kuhad A; Arora V
    Expert Opin Ther Targets; 2011 Nov; 15(11):1267-81. PubMed ID: 21905964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibromyalgia syndrome: the pharmacological treatment options.
    Sarzi-Puttini P; Torta R; Marinangeli F; Biasi G; Spath M; Buskila D; Gracely RH; Giamberardino MA; Bazzichi L; Cazzola M; Di Franco M; Stisi S; Salaffi F; Casale R; Leardini G; Gorla R; Marsico A; Carignola R; Altomonte L; Ceccherelli F; Cassisi G; Arioli G; Alciati A; Atzeni F;
    Reumatismo; 2008; 60 Suppl 1():50-8. PubMed ID: 18852908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical overview of fibromyalgia.
    McCarberg BH
    Am J Ther; 2012 Sep; 19(5):357-68. PubMed ID: 21326083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term maintenance of response across multiple fibromyalgia symptom domains in a randomized withdrawal study of pregabalin.
    Pauer L; Atkinson G; Murphy TK; Petersel D; Zeiher B
    Clin J Pain; 2012 Sep; 28(7):609-14. PubMed ID: 22688598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.